CARD14 Gain-of-Function Mutation Alone Is Sufficient to Drive IL-23/IL-17–Mediated Psoriasiform Skin Inflammation In Vivo

MLA

Deepa Mohanan, et al. “CARD14 Gain-of-Function Mutation Alone Is Sufficient to Drive IL-23/IL-17–Mediated Psoriasiform Skin Inflammation In Vivo.” Journal of Investigative Dermatology, vol. 138, Sept. 2018, pp. 2010–23. EBSCOhost, https://doi.org/10.1016/j.jid.2018.03.1525.

APA

Deepa Mohanan, Stephan Nobbe, Lars E. French, Caroline Ospelt, Mark Mellett, Emmanuel Contassot, Barbara Meier, Phil F. Cheng, Margot Thome, Betina Kiefer, Rebekka Schairer, & Takashi K. Satoh. (2018). CARD14 Gain-of-Function Mutation Alone Is Sufficient to Drive IL-23/IL-17–Mediated Psoriasiform Skin Inflammation In Vivo. Journal of Investigative Dermatology, 138, 2010–2023. https://doi.org/10.1016/j.jid.2018.03.1525

Chicago

Deepa Mohanan, Stephan Nobbe, Lars E. French, Caroline Ospelt, Mark Mellett, Emmanuel Contassot, Barbara Meier, et al. 2018. “CARD14 Gain-of-Function Mutation Alone Is Sufficient to Drive IL-23/IL-17–Mediated Psoriasiform Skin Inflammation In Vivo.” Journal of Investigative Dermatology 138 (September): 2010–23. doi:10.1016/j.jid.2018.03.1525.